SOW
UTHR icon

State of Wyoming’s United Therapeutics UTHR Stock Holding History

State of Wyoming’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-185
Closed -$77.6K – 2106
2025
Q3 		$77.6K Sell
185
-5
-3% -$1.68K 0.01% 1386
2025
Q2 		$54.6K Buy
+190
New +$56.8K 0.01% 1533
2025
Q1 		– Sell
-177
Closed -$62.5K – 1857
2024
Q4 		$62.5K Buy
+177
New +$65.1K 0.01% 1330
2022
Q2 		– Sell
-1,771
Closed -$318K – 2147
2022
Q1 		$318K Buy
1,771
+59
+3% +$11.2K 0.16% 71
2021
Q4 		$370K Buy
1,712
+125
+8% +$24.5K 0.17% 71
2021
Q3 		$293K Sell
1,587
-462
-23% -$91K 0.19% 85
2021
Q2 		$368K Buy
+2,049
New +$390K 0.23% 63

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

State of Wyoming's UTHR Position: Q4 2025 in Review

State of Wyoming sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 185 shares — an estimated $77.6K sold.

State of Wyoming first reported a position in UTHR in Q2 2021 and held it in 7 quarters. The position peaked at $370K in Q4 2021. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • State of Wyoming reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • State of Wyoming sold 185 United Therapeutics shares in Q4 2025, an estimated $77.6K.
  • State of Wyoming first reported a position in United Therapeutics in Q2 2021 and held it in 7 quarters.
  • State of Wyoming's United Therapeutics position peaked at $370K in Q4 2021.
  • 838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on State of Wyoming's 13F filing for Q4 2025, filed 11 Feb 2026.